All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

Alentis Therapeutics

Alentis Therapeutics develops anti-Claudin-1 antibodies and antibody-drug conjugates for Claudin-...

Basel, Switzerland51–200Biotech, Drug Discovery
Series DTotal funding$365.9MNov 2024
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series CTotal funding$363.0MJan 2025
Ventus Therapeutics

Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...

Montreal, Canada11–50Biotech, Drug Discovery
GrantTotal funding$360.1MApr 2023
Tata 1mgAcquired

Indian online pharmacy and healthcare platform offering medicines, lab tests, doctor consultation...

Gurugram, India1001–5000E-Commerce, Healthcare
Extension RoundTotal funding$356.1MSep 2025
Capstan TherapeuticsAcquired

Biotech developing in vivo CAR-T cell therapies. Acquired by AbbVie for $2.1B upfront in 2024.

San Diego, United States51–200Biotech, Drug Discovery
Series BTotal funding$340.0MMar 2024
Neuron23

Clinical-stage biotech developing precision medicines for genetically defined Parkinson’s disease...

South San Francisco, United States11–50Biotech, Drug Discovery
Series DTotal funding$310.0MJun 2025
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$304.5MMar 2025
Cellarity

Cellarity develops oral therapeutics that correct cell-state dysfunction using an integrated mult...

Somerville, United States51–200Artificial Intelligence, Biotech
Series CTotal funding$294.0MOct 2022
Octant Bio

Small molecule correctors for protein misfolding, enabled by a synthetic biology, high throughput...

Los Angeles, United States51–200Healthcare, Biotech
Series CTotal funding$290.2MOct 2025
BenchSci

AI-powered platform that accelerates drug discovery by helping pharmaceutical researchers find th...

Toronto, Canada201–500Artificial Intelligence, Drug Discovery
Series DTotal funding$265.2MMay 2023
FibroGenIPO

Develops novel therapeutics in oncology and anemia, advancing antibody-drug conjugates and HIF-PH...

San Francisco, United States11–50Biotech, Life Sciences
Venture RoundTotal funding$261.5MNov 2022
Frontier Medicines

Clinical-stage precision-medicine biotech using chemoproteomics and AI to discover covalent small...

San Francisco, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$255.5MJun 2024
Vir

Clinical-stage biopharmaceutical company leveraging the immune system to develop medicines for in...

San Francisco, United States201–500Biotech, Healthcare
Growth EquityTotal funding$250.0MOct 2024
InventisBioIPO

InventisBio develops clinical-stage medicines for oncology, autoimmune diseases, and metabolic di...

Shanghai, China11–50Biotech, Life Sciences
Series DTotal funding$247.0MSep 2020
Seismic Therapeutic

Clinical-stage immunology biotech using machine learning to design biologic therapeutics for auto...

Cambridge, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$247.0MJul 2025
Agios PharmaceuticalsIPO

Agios develops medicines for rare diseases by applying cellular-metabolism science, with programs...

Cambridge, United States501–1000Biotech, Drug Discovery
Series CTotal funding$241.0MNov 2011
DalCor Pharmaceuticals

DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic p...

Drug Discovery, Genomics
Series DTotal funding$230.0MSep 2023
Engrail Therapeutics

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted the...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$221.0MMar 2024
BenevolentAI

AI-enabled drug discovery company using machine learning and knowledge graphs to identify novel d...

London, United Kingdom201–500Drug Discovery, Artificial Intelligence
Series DTotal funding$217.8MJan 2020
DP Technology

DP Technology creates AI scientists, intelligent systems, and scientific tools spanning modern re...

Beijing, China201–500Artificial Intelligence, Drug Discovery
Series CTotal funding$213.7MDec 2025
Atomwise

AI-native drug discovery company, now operating as Numerion Labs, that uses machine learning to e...

San Francisco, United States51–200Biotech, Artificial Intelligence
Series CTotal funding$213.0MMar 2024
Intarcia TherapeuticsClosed

Intarcia Therapeutics is a biopharmaceutical company based in Boston, MA, dedicated to developing...

San Francisco, United States201–500Drug Discovery
Venture RoundTotal funding$210.0MNov 2012
SchrödingerIPO

Physics-based computational platform for molecular design that helps pharmaceutical, biotechnolog...

New York, United States501–1000Artificial Intelligence, Biotech
GrantTotal funding$205.0MJul 2024
Terray Therapeutics

AI-native biotech company using ultra-miniaturized chemistry hardware and machine learning for sm...

Monrovia, United States51–200Artificial Intelligence, Biotech
Series BTotal funding$200.0MOct 2024
Scipher Medicine

Precision immunology company using AI and clinico-genomic data to match autoimmune patients with ...

Boston, United States51–200Artificial Intelligence, Drug Discovery
Series DTotal funding$197.8MJul 2024